Search

PROCEPT BioRobotics Corp

Chiusa

SettoreSettore sanitario

20.28 2.68

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

20.28

Massimo

21.21

Metriche Chiave

By Trading Economics

Entrata

-1.8M

-32M

Vendite

6.7M

83M

EPS

-0.56

Margine di Profitto

-38.058

Dipendenti

888

EBITDA

-7.3M

-29M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+13.33% upside

Dividendi

By Acuity

Utili prossimi

3 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-325M

1B

Apertura precedente

17.6

Chiusura precedente

20.28

Notizie sul Sentiment di mercato

By Acuity

50%

50%

128 / 340 Classifica in Healthcare

PROCEPT BioRobotics Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 ago 2026, 20:02 UTC

News

Procept Biorobotics shares are higher as analysts adjust ratings; Wells Fargo sets target at $19.00, while UBS downgrades to "neutral" with a $20.00 target.

6 ago 2026, 20:03 UTC

Procept Biorobotics shares are higher Thursday, recovering from an earlier decline. The stock closed above its 20-day moving average amid broader market dynamics.

5 ago 2026, 19:52 UTC

News

Procept Biorobotics shares are higher as TD Cowen maintains a Buy rating and Piper Sandler reiterates its Overweight rating amid increased investor engagement.

4 ago 2026, 23:02 UTC

News

Procept Biorobotics reported a second-quarter loss of $26.9 million and shares are trading lower in after-market hours following the earnings report.

3 ago 2026, 20:03 UTC

News

Procept Biorobotics shares decline amid a securities class action lawsuit alleging financial misrepresentation through inflated sales and excess inventory.

31 lug 2026, 20:02 UTC

News

Procept Biorobotics shares are rising today, even after UBS downgraded its rating to neutral with a $20 price target.

30 lug 2026, 19:58 UTC

Procept Biorobotics Corp is rising during Thursday's session, driven by a broader market rally and recovery in technology shares. No specific company news was identified.

29 lug 2026, 16:26 UTC

Procept Biorobotics Corp shares are higher Wednesday, recovering from earlier losses amid broader market volatility ahead of the Federal Reserve's interest rate decision.

28 lug 2026, 19:26 UTC

Procept Biorobotics Corp shares are trading higher, reflecting a cumulative gain since Monday, despite negative sentiment from declines in Asian markets.

27 lug 2026, 17:02 UTC

News

Procept Biorobotics reported Q1 revenue of $83.1 million, a 20% increase. Shares are trading higher, recovering from recent declines since Friday's close.

22 lug 2026, 19:41 UTC

Procept Biorobotics Corp shares are lower today, diverging from recent gains. Broader market concerns include rising crude oil prices and inflationary pressures.

21 lug 2026, 16:01 UTC

Procept Biorobotics Corp is declining during Tuesday's session, breaking a trend of higher daily closes. No specific news was identified for the move.

20 lug 2026, 19:56 UTC

Procept Biorobotics Corp shares are higher today, despite earlier volatility and no specific news. Broader market performance remains mixed amid geopolitical tensions.

Confronto tra pari

Modifica del prezzo

PROCEPT BioRobotics Corp Previsione

Obiettivo di Prezzo

By TipRanks

13.33% in crescita

Previsioni per 12 mesi

Media 23.13 USD  13.33%

Alto 29 USD

Basso 19 USD

Basato su 11 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per PROCEPT BioRobotics Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

11 ratings

3

Acquista

7

Mantieni

1

Vendi

Sentiment

By Acuity

128 / 340 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo PROCEPT BioRobotics Corp

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
help-icon Live chat